14 drugs identified as most urgently needing study for off-label use, Stanford professor says

Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval — a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it.

Read the whole article on Physorg

More from Physorg